Lord, Abbett & Co’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-147,386
Closed -$5.28M 663
2020
Q3
$5.28M Sell
147,386
-9,008
-6% -$271K 0.02% 561
2020
Q2
$3.78M Sell
156,394
-83,108
-35% -$1.95M 0.01% 592
2020
Q1
$4.19M Buy
239,502
+6,860
+3% +$143K 0.02% 556
2019
Q4
$4.05M Sell
232,642
-937,242
-80% -$15.6M 0.01% 611
2019
Q3
$17.9M Sell
1,169,884
-576,042
-33% -$11M 0.06% 427
2019
Q2
$36.2M Buy
1,745,926
+89,677
+5% +$2.01M 0.12% 298
2019
Q1
$38.5M Buy
1,656,249
+217,641
+15% +$4.55M 0.13% 258
2018
Q4
$29.7M Buy
1,438,608
+313,153
+28% +$5.68M 0.11% 290
2018
Q3
$24.5M Buy
1,125,455
+761,599
+209% +$12.6M 0.07% 430
2018
Q2
$5.55M Buy
363,856
+79,244
+28% +$1.49M 0.02% 725
2018
Q1
$5.6M Buy
+284,612
New +$5.85M 0.02% 707

Other funds holding DNLI